Get started
Author

Xin Chen-Zhao

Observed names: X. Chen Zao, X. Chen-Zhao, Xin Chen Zao
ORCID: 0000-0002-5118-1513
Observed ORCID: 0000-0002-5118-1513
OpenAlex ID: A5038070314
Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity results
2024 · Ivica Ratosa, Angel Montero, et al. · Clinical and Translational Radiation Oncology · 21
PDF
Low-dose radiation therapy for hand osteoarthritis: shaking hands again?
2021 · B. Álvarez, A. Montero, et al. · Clinical & Translational Oncology · 20
A prospective observational study of the clinical and pathological impact of stereotactic body radiotherapy (SBRT) as a neoadjuvant strategy of chemoradiation in pancreatic cancer
2020 · X. Chen-Zhao, O. Hernando, et al. · Clinical & Translational Oncology · 20
Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer
2023 · Angel Montero, Raquel Ciérvide, et al. · Clinical and Translational Radiation Oncology · 18
PDF
SBRT-SG-01: final results of a prospective multicenter study on stereotactic body radiotherapy for liver metastases
2024 · María-Carmen Rubio Rodríguez, Xin Chen-Zhao, et al. · Clinical & Translational Oncology · 12
Diagnosis and management of spinal metastasis of primary brain tumours
2018 · Xin Chen-Zhao, Luis Aznar-García · AME Case Reports · 11
PDF
Moderate hypofractionated radiation therapy and pathologic response for soft tissue sarcomas (STS) of limbs and trunk: experience from a tertiary cancer center
2023 · Angel Montero, Xin Chen-Zhao, et al. · Clinical & Translational Oncology · 10
Radiation therapy with curative intention in men with de novo metastatic prostate carcinoma: shoot'em all!
2021 · Angel Montero, Ovidio Hernando, et al. · PubMed · 10
Moderate hypofractionated post-prostatectomy radiation therapy is feasible and well tolerated: experience from a single tertiary cancer centre
2021 · J. Valero, A. Montero, et al. · Clinical & Translational Oncology · 6
Analysis of intra-fractional positioning correction performed by cone beam computed tomography in SBRT treatments
2024 · P García-Acilu, J. García Ruiz-Zorrilla, et al. · Physica Medica · 5
Real-world efficacy of postoperative radiotherapy with a moderate dose-escalation for phyllodes tumors of the breast
2023 · Beatriz Álvarez, Angel Montero, et al. · Translational Breast Cancer Research · 5
PDF
Single and multitarget stereotactic radiosurgery (SRS) with single isocenter in the treatment of multiple brain metastases (BM): institutional experience
2025 · Raquel Ciérvide, Jaime Martí, et al. · Clinical & Translational Oncology · 4
SABR tolerance after prostatectomy: pushing the boundaries of ultrahypofractionation
2025 · Angel Montero, Ovidio Hernando, et al. · Clinical & Translational Oncology · 3
Comparison between RECIST 1.1, Choi and PERCIST 1.0 criteria to evaluate response to SBRT of liver metastasis
2021 · María Allona Krauel, Xin Chen-Zhao, et al. · AME Medical Journal · 3
Implementing a low-dose radiation therapy program for musculoskeletal pain disorders: tips, tricks, and essentials for clinical researchers
2025 · Beatriz Álvarez, Angel Montero, et al. · Clinical & Translational Oncology · 2
Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis
2024 · Mercedes López Gonzalez, Ovidio Hernando-Requejo, et al. · Clinical & Translational Oncology · 2
PD-0576 Ultra-hypofractionated SBRT following radical prostatectomy: first results of a phase II trial
2022 · A. Montero, O. Hernando, et al. · Radiotherapy and Oncology · 1
PO-1135 Ultra-hypofractionated whole breast radiotherapy with integrated boost for early breast cancer
2021 · A. Montero, R. Ciervide, et al. · Radiotherapy and Oncology · 1
Perioperative high-dose-rate brachytherapy (PoHDR) in the multidisciplinary management of adult soft tissue sarcomas: a realistic alternative for a moderate radiotherapy dose escalation
2020 · Xin Chen-Zhao, Angel Montero, et al. · Journal of Radiation Oncology · 1
Total neoadjuvant therapy with dose-escalated radiotherapy for organ preservation in locally advanced rectal cancer: real-world outcomes
2026 · O. Hernando-Requejo, M. López González, et al. · Strahlentherapie und Onkologie
One Week, One Boost, One Goal: Feasibility, Safety and Local Control in Breast Ductal Carcinoma In Situ With Ultra-hypofractionated Radiotherapy and Simultaneous Integrated Boost
2025 · A. Montero, R. Ciervide, et al. · Clinical Oncology
Beyond the knife: HDR plesiotherapy brings precision to atypical fibroxanthoma
2025 · Carmen Saiz, Angel Montero, et al. · ecancermedicalscience
PDF
Clinician- and Patient-Reported Outcomes of Stereotactic Ablative Radiation Therapy for High-Risk Prostate Cancer
2025 · Helena B.Z. Logar, Angel Montero, et al. · Practical Radiation Oncology
317 Single-center experience using moderate hypofractionation within chemoradiotherapy for limited stage small cell lung cancer
2025 · Bruno E. Zambrana Moreno, Beatriz Álvarez Rodríguez, et al. · Radiotherapy and Oncology
1155 One-Hundred-and-One DCIS: Hunting down safe and effective results with 5-day ultra-hypofractionated irradiation
2025 · Angel Montero, Raquel Ciervide, et al. · Radiotherapy and Oncology
Works count: 41
Citation count: 155
H-index: 8
I10-index: 8
Year
Topic
Type